Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 3/20 | 0.47 |
| ▸ | CCR5 | P51681 | 3/20 | 0.47 |
| ▸ | CCR8 | P51685 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.46 |
| ▸ | LMNA | P02545 | 5/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.46 |
| ▸ | TP53 | P04637 | 4/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | ALPL | P05186 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | ALPI | P09923 | 1/20 | 0.46 |
| ▸ | ALPG | P10696 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | RAB9A | P51151 | 5/20 | 0.43 |
| ▸ | PKM | P14618 | 3/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL7553420 | 0.98 | CCR1 (0.46) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL30943430 | 0.92 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL29505007 | 0.92 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL3596420 | 0.92 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL21849866 | 0.92 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL30943427 | 0.92 | CCR1 (0.55) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL4401831 | 0.89 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL3315795 | 0.89 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL19320191 | 0.89 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ELMNA | |
| SCHEMBL3319965 | 0.89 | MCL1 (0.56) | CCR1CCR5CCR8KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0885233-B1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION (GB) | 2002-06-19 | — | — | EP | disclosed |
| US-20020013306-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | ISIS INNOVATION LIMITED (GB) | 2002-01-31 | — | — | US | disclosed |
| EP-1164138-A1 | Terpyridine-platinum (II) complexes | ISIS INNOVATION LIMITED (GB) | 2001-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013306-A1 | TERPYRIDINE-PLATINUM(II) COMPLEXES | TOP2A, TOP1, TOP2B | CCR1 1921/4885CCR5 884/4885CCR8 1209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.